Roche signs $400 million upfront deal with China's Hansoh, potential $15 billion partnership

Roche announced a major collaboration with Chinese biotech Hansoh, committing $400 million upfront.

The agreement gives Roche access to Hansoh's drug discovery platform and aims to co-develop candidates for global markets.

The deal could expand to $15 billion in biobucks, marking one of the largest cross-border pharma collaborations this year and underscoring Roche's focus on China.